Return-on-Tangible-Equity is calculated as Net Income divided by its average total shareholder tangible equity. Total shareholder tangible equity equals to Total Stockholders Equity minus Intangible Assets. Inspire Medical Systems's annualized net income for the quarter that ended in Mar. 2026 was €-39.1 Mil. Inspire Medical Systems's average shareholder tangible equity for the quarter that ended in Mar. 2026 was €676.2 Mil. Therefore, Inspire Medical Systems's annualized Return-on-Tangible-Equity for the quarter that ended in Mar. 2026 was -5.78%.
The historical rank and industry rank for Inspire Medical Systems's Return-on-Tangible-Equity or its related term are showing as below:
STU:2DR'
s Return-on-Tangible-Equity Range Over the Past 10 Years
Min: -30.96 Med: -15.36 Max: 19.77
Current: 18.45
During the past 11 years, Inspire Medical Systems's highest Return-on-Tangible-Equity was 19.77%. The lowest was -30.96%. And the median was -15.36%.
STU:2DR's Return-on-Tangible-Equity is ranked better than 82.03% of 757
companies
in the Medical Devices & Instruments industry
Industry Median: 4.09
vs STU:2DR: 18.45
Inspire Medical Systems (STU:2DR) Return-on-Tangible-Equity Explanation
Return-on-Tangible-Equity measures the rate of return on the ownership interest (shareholder's tangible equity) of the common stock owners. It measures a firm's efficiency at generating profits from every unit of shareholders' tangible equity (shareholders equity minus intangibles). Return-on-Tangible-Equity shows how well a company uses investment funds to generate earnings growth. Return-on-Tangible-Equitys between 15% and 20% are considered desirable.
Be Aware
Net Income is used.
Because a company can increase its Return-on-Tangible-Equity by having more financial leverage, it is important to watch the leverage ratio when investing in high Return-on-Tangible-Equity companies. Like Return-on-Tangible-Asset, Return-on-Tangible-Equity is calculated with only 12 months data. Fluctuations in company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.
Asset light businesses require very few assets to generate very high earnings. Their Return-on-Tangible-Equitys can be extremely high.
Inspire Medical Systems Return-on-Tangible-Equity Related Terms
Inspire Medical Systems Return-on-Tangible-Equity Historical Data
* Premium members only.
The historical data trend for Inspire Medical Systems's Return-on-Tangible-Equity can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Inspire Medical Systems Return-on-Tangible-Equity Chart
STU:2DR vs ENOV, PRCT, AHCO: Return-on-Tangible-Equity Comparison
For the Medical Devices subindustry, Inspire Medical Systems's Return-on-Tangible-Equity, along with its competitors' market caps and Return-on-Tangible-Equity data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Inspire Medical Systems Return-on-Tangible-Equity vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Inspire Medical Systems's Return-on-Tangible-Equity distribution charts can be found below:
* The bar in red indicates where Inspire Medical Systems's Return-on-Tangible-Equity falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual Return-on-Tangible-Equity, the net income of the last fiscal year and the average total shareholder tangible equity over the fiscal year are used. In calculating the quarterly data,
the net income data used here is four times the quarterly (Mar. 2026) net income data.
Return-on-Tangible-Equity is displayed in the 10-year financial page.
What does a Return-on-Tangible-Equity of -5.78% mean?
Inspire Medical Systems (STU:2DR) has a Return-on-Tangible-Equity of -5.78% as of Mar. 2026. Return on tangible equity is the ratio of current-period net income to average two-period tangible equity. View historical data on Inspire Medical Systems and its competitors. According to the industry distribution chart, Inspire Medical Systems ranks #136 out of 757 companies in the Medical Devices & Instruments industry, placing it in the top 18%.
Is Inspire Medical Systems' Return-on-Tangible-Equity too high?
Inspire Medical Systems' current Return-on-Tangible-Equity is -5.78%. Based on the distribution chart, Inspire Medical Systems ranks #136 out of 757 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, Inspire Medical Systems has a GF Score™ of 55/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Inspire Medical Systems' Return-on-Tangible-Equity compare to ENOV and PRCT?
According to the Medical Devices & Instruments industry distribution chart, Inspire Medical Systems ranks #136 out of 757 companies for Return-on-Tangible-Equity. This places Inspire Medical Systems in the top 18% of its industry — outperforming the majority of peers. The industry median Return-on-Tangible-Equity is 4.09. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Return-on-Tangible-Equity for a Medical Devices & Instruments company?
The median Return-on-Tangible-Equity among Medical Devices & Instruments companies is 4.09, based on 757 companies in the industry. Companies in the top quartile (top 25%) have a Return-on-Tangible-Equity significantly above this median, while those in the bottom quartile fall well below. However, Return-on-Tangible-Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Return-on-Tangible-Equity mean?
A high Return-on-Tangible-Equity can signal that a stock is expensive relative to its fundamentals. Return on tangible equity is the ratio of current-period net income to average two-period tangible equity. View historical data on Inspire Medical Systems and its competitors. For the Medical Devices & Instruments industry, the median Return-on-Tangible-Equity is 4.09 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Inspire Medical Systems's current Return-on-Tangible-Equity is -5.78%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Inspire Medical Systems stock overvalued right now?
Based on GuruFocus' analysis, Inspire Medical Systems (STU:2DR) is currently considered Possible Value Trap. The stock's GF Value™ is €188.74, compared to a current price of €43.00 — trading 77.2% below its estimated fair value. The current Return-on-Tangible-Equity is -5.78%. Inspire Medical Systems' overall GF Score™ is 55/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Return-on-Tangible-Equity calculated?
Return-on-Tangible-Equity is calculated from a company's financial statements. For Inspire Medical Systems (STU:2DR), the current Return-on-Tangible-Equity is -5.78% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Inspire Medical Systems (STU:2DR) Overvalued in 2026?
Based on GuruFocus' analysis, Inspire Medical Systems stock appears to be undervalued.
The current stock price of €43.00 is trading 77.2% below its estimated GF Value™ of €188.74.
GuruFocus considers Inspire Medical Systems to be Possible Value Trap.
Key valuation signals for STU:2DR:
Return-on-Tangible-Equity: -5.78%
GF Value™: €188.74 vs. price of €43.00 (77.2% below fair value)
No single metric tells the full story. See the STU:2DR stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Inspire Medical Systems Inc operates as a medical technology company. It focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA). It offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe obstructive sleep apnea. The firm has operating footprints in the United States and All other countries wherein, it generates a majority of its revenue from the United States. Its segment revenues are derived from the sales of its product, the Inspire system, to hospitals and ambulatory surgery centers in the U.S. and in selected countries in Europe and the Asia Pacific region.
55GF Score
Get the complete analysis for STU:2DR
Return-on-Tangible-Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
STU:2DR has been successfully added to your 
